Caricamento...

Acute myeloid leukemia: current progress and future directions

Progress in the understanding of the biology and therapy of acute myeloid leukemia (AML) is occurring rapidly. Since 2017, nine agents have been approved for various indications in AML. These included several targeted therapies like venetoclax, FLT3 inhibitors, IDH inhibitors, and others. The manage...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Blood Cancer J
Autori principali: Kantarjian, Hagop, Kadia, Tapan, DiNardo, Courtney, Daver, Naval, Borthakur, Gautam, Jabbour, Elias, Garcia-Manero, Guillermo, Konopleva, Marina, Ravandi, Farhad
Natura: Artigo
Lingua:Inglês
Pubblicazione: Nature Publishing Group UK 2021
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7900255/
https://ncbi.nlm.nih.gov/pubmed/33619261
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41408-021-00425-3
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !